Cutler Group LLC / CA - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$0
-100.0%
3,200
-74.6%
0.00%
-100.0%
Q4 2020$70,000
+3400.0%
12,600
+37.0%
0.00%
Q2 2020$2,000
-99.8%
9,200
-56.6%
0.00%
-100.0%
Q3 2019$1,244,000
+31000.0%
21,200
+253.3%
0.11%
Q3 2017$4,000
-84.0%
6,000
+844.9%
0.00%
-100.0%
Q4 2016$25,000635
+27.0%
0.00%
Q1 2016$05000.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders